Origen Therapeutics, Inc.

Origen Therapeutics is a biotechnology company developing product opportunities arising from the emerging field of avian transgenic animal technology. The company's mission is to become the leading developer of a novel class human immunotherapeutics known as fully human sequence polyclonal antibodies. These antibodies are expected to have significant advantages over monoclonal antibodies that currently are in great favor amongst developers of human therapeutics. Origen plans to create corporate alliances with biotechnology and large pharmaceutical companies for the commercialization of these products

Contact Details: 1450 Rollins Road Burlingame California 94010 United States of America Tel: (650) 558 7700 Fax: (650) 558 7799 Email: info@origentherapeutics.com WWW: www.origentherapeutics.com/

Loading...

Origen Therapeutics, Inc. Patents:
US Patent No.	Title
7323618	Tissue specific expression of exogenous proteins in transgenic chickens
7145057	Chimeric bird from embryonic stem cells
6861572	Production of proteins in eggs

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 766 times since April 2007, the link to the organisation's website has been followed 193 times

Recent Search Terms used to find this page: origen drug discovery | ORIGEN THERAPEUTICS INC | Origen Therapeutics | Origen Therapeutics | origen therapeutics | origen therapeutics inc | Origen Therapeutics | ORIGEN THERAPEUTICS INC | origen therapeutics | origen therapeutics patents | .

Search for more companies in Burlingame

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Origen Therapeutics, Inc.